Form D · Biotechnology
Paratus Diagnostics, LLC
San Marcos, TX · CIK 0001661922
Offering snapshot reported Nov 29, 2018 · SEC filing
- Reported sold
- $5.21M Offering amount: $8.21M
- Investors reported
- 43 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Nov 16, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 29, 2018 | Initial | $5,205,000 | No comparison | 43 | SEC filing |
| Jul 21, 2016 | Initial | $2,800,000 | No comparison | 43 | SEC filing |
| Dec 28, 2015 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-326899
Source: Form D, filed Nov 29, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gene Betts | Director |
| John C. Carrano | Director, Executive |
| Robert Donnelly | Director |
| Phil Jones | Director |
| Michael Matula | Director |
| Wayne Radwanski | Director, Executive |
| Roland Q Schneider | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3055 Hunter Road
San Marcos, TX, 78666
San Marcos, TX, 78666